Site Search
653 Results (showing 1 - 25)
Jun 30, 2011
Life Tech, Persistent Developing Software for CE Sequencing Data Analysis
The firms intend to file the software with the US Food and Drug Administration for molecular diagnostic applications.
Jun 30, 2011
Horizon Secures Distribution Rights to New X-Man Cell Lines from Japanese University
The new X-Man cell lines are focused on DNA repair and include important double knockout cell lines.
Jun 30, 2011
Cosmo Bio Distributing SwitchGear System in Japan
Cosmo Bio will distribute the LightSwitch Luciferase Assay System with marketing and technical support from SwitchGear.
Jun 30, 2011
Genomics in the Journals: Jun 30, 2011
In the journals this week: gene expression rhythms in malaria-spreading mosquitoes, re-creating cancer mutation history, a new leaf-cutter ant genome, and more.
Jun 30, 2011
Cost-Benefit Analysis
Premium
A new lung cancer test could save lives, but does it cost too much?
Jun 30, 2011
This Week in NEJM: Jun 30, 2011
Premium
In NEJM this week: reducing lung cancer mortality, and more.
Jun 30, 2011
Analyzing Ovarian Cancer
Premium
TCGA researchers complete a large study on ovarian cancer genome.
Jun 30, 2011
Data Control and Sharing
Premium
Databases of genetic information underscore the conflict -between control of data, and sharing of research resources, particularly affecting indigenous populations.
Jun 30, 2011
Stressed Out
Premium
When a labmate — particularly a postdoc — is cracking under
the pressure to produce, the signs can be varied and subtle.
Jun 30, 2011
In review
Jun 30, 2011
What Price Innovation?
Premium
A study showing the superiority of HHMI's funding approach has the community ready to throw NIH under the bus. But that wasn't the point.
Jun 30, 2011
Open Source R&D
Should the research model be changed to resemble the way Hollywood does business?
Jun 30, 2011
Survey: Public Supports Biotech
A new survey shows that the American public wants the government to help biotech cure disease.
Jun 30, 2011
Danaher Completes Beckman Coulter Acquisition
The tender offer period finished with around 92 percent of Beckman Coulter shareholders tendering their shares.
Jun 30, 2011
Thermo Fisher Establishes Credit Facilities of $3B to Finance Phadia Purchase
The company has entered a bridge credit agreement for $2 billion and a revolving credit agreement for up to $1 billion.
Jun 30, 2011
Epistem, Xcelris Evaluating Point-of-Need MDx Device for TB Identification
The two firms are collaborating to evaluate Epistem's Genedrive device as part of an Indian program to diagnose and treat TB rapidly.
Jun 30, 2011
Metamark, Definiens Partner on Cancer Dx
The collaboration will combine Metamark's multiplex protein detection platform with image analysis technology that the firm will jointly develop with Definiens.
Jun 30, 2011
CLC Bio, Riken to Provide Free Software to Researchers in Earthquake, Tsunami Area
Free licenses for CLC Main Workbench will be provided to all academic organizations in the Tohoku earthquake and tsunami disaster area.
Jun 30, 2011
One-Stop Shopping
The NIH highlights its family-friendly programs and policies on a new Web page.
Jun 30, 2011
A Matter of Access?
One blogger says genomic medicine could cause 'an immense explosion in health inequality.'
Jun 30, 2011
This Week in Nature : Jun 30, 2011
In Nature this week: combinatorial effect of nucleotide substitutions on D. sechellia larval morphology, integrated genomic analyses for ovarian carcinoma, ZFNs and genome editing, and more.
Jun 30, 2011
Alnylam charged Tekmira with wrongly using trade secrets to bolster its own drug delivery technology-development efforts and to file a patent application on Alnylam's phase I liver cancer drug.
Jun 30, 2011
The publication comes as the RNAi Consortium looks to expand its work beyond gene silencing to include gain-of-function research.
Jun 30, 2011
The grants will support research into the role of miRNAs in brain disease and health, as well as gastrointestinal disorders.
Jun 30, 2011
The partnership will specifically include STP601, Sirnaomics' preclinical treatment for ocular neovascularization diseases, in the Greater China and Southeast Asian markets.